Position in ZNTL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,442,283
+$1,077,937 QoQ
Shares Held
297,378
+91.0% QoQ
Ownership
0.415%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 114 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. ZNTL ranks #239 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ZNTL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,442,283 | 297,378 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $364,346 | 155,704 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $910,707 | 674,598 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $804,343 | 532,678 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $150,182 | 129,468 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $225,678 | 141,936 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $556,544 | 183,678 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $108,663 | 29,528 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $438,038 | 107,100 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,221,552 | 267,865 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,666 | 110 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,340,669 | 66,833 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,531,931 | 89,753 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,434,634 | 83,409 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,119,524 | 154,892 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $541,390 | 24,995 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $838,588 | 29,843 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,426,125 | 74,255 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,984,632 | 35,506 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,659 | 265 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,566 | 255 | Shares | Defined | 2021-08-13 | |
| 2020-12-31 | $9,453 | 182 | Shares | Sole | 2021-02-11 | |
| 2020-06-30 | $12,341 | 257 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||